Method comparison of SARS-CoV-2 serology assays involving three commercially available platforms and a novel in-house developed enzyme-linked immunosorbent assay

Detalles Bibliográficos
Autores principales: Seegmiller, Jesse C., Kokaisel, Emily L., Story, Steven J., Zaun, Christopher P., Peters, Jennifer M., Thomas, Stefani N., Karger, Amy B.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Published by Elsevier Inc. on behalf of The Canadian Society of Clinical Chemists. 2020
Materias:
Letter to the Editor
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7417259/
https://www.ncbi.nlm.nih.gov/pubmed/32791053
http://dx.doi.org/10.1016/j.clinbiochem.2020.08.004

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7417259/
https://www.ncbi.nlm.nih.gov/pubmed/32791053
http://dx.doi.org/10.1016/j.clinbiochem.2020.08.004

Ejemplares similares